- Home
- LXRX vs CDZI Comparison
LXRX vs CDZI Comparison
Compare LXRX & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- CDZI
- Stock Information
- Founded
- LXRX 1995
- CDZI 1983
- Country
- LXRX United States
- CDZI United States
- Employees
- LXRX N/A
- CDZI N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- CDZI Water Supply
- Sector
- LXRX Health Care
- CDZI Utilities
- Exchange
- LXRX Nasdaq
- CDZI Nasdaq
- Market Cap
- LXRX 228.8M
- CDZI 238.2M
- IPO Year
- LXRX 2000
- CDZI N/A
- Fundamental
- Price
- LXRX $0.63
- CDZI $3.18
- Analyst Decision
- LXRX Buy
- CDZI
- Analyst Count
- LXRX 4
- CDZI 0
- Target Price
- LXRX $3.67
- CDZI N/A
- AVG Volume (30 Days)
- LXRX 4.1M
- CDZI 412.0K
- Earning Date
- LXRX 05-13-2025
- CDZI 05-14-2025
- Dividend Yield
- LXRX N/A
- CDZI N/A
- EPS Growth
- LXRX N/A
- CDZI N/A
- EPS
- LXRX N/A
- CDZI N/A
- Revenue
- LXRX $31,213,000.00
- CDZI $11,441,000.00
- Revenue This Year
- LXRX N/A
- CDZI $75.05
- Revenue Next Year
- LXRX $46.60
- CDZI $12.18
- P/E Ratio
- LXRX N/A
- CDZI N/A
- Revenue Growth
- LXRX 1251.21
- CDZI 283.67
- 52 Week Low
- LXRX $0.28
- CDZI $2.13
- 52 Week High
- LXRX $2.45
- CDZI $5.68
- Technical
- Relative Strength Index (RSI)
- LXRX 51.48
- CDZI 59.77
- Support Level
- LXRX $0.62
- CDZI $2.76
- Resistance Level
- LXRX $0.72
- CDZI $3.06
- Average True Range (ATR)
- LXRX 0.05
- CDZI 0.19
- MACD
- LXRX -0.00
- CDZI 0.02
- Stochastic Oscillator
- LXRX 59.81
- CDZI 69.74
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About CDZI CADIZ Inc.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.